A A Verberne
Overview
Explore the profile of A A Verberne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Steenhuis T, Landstra A, Verberne A, van Aalderen W
BioDrugs
. 2007 Nov;
12(6):431-8.
PMID: 18031192
Nocturnal symptoms of asthma such as coughing, wheezing, dyspnoea and dyspnoea on awakening are common in children with asthma. This is an important issue since nocturnal symptoms may have a...
2.
Verberne A, de Jongste J
Pediatr Pulmonol
. 2000 Feb;
29(3):169-71.
PMID: 10686035
No abstract available.
3.
Verbeke J, Verberne A, den Hollander J, Robben S
Pediatr Radiol
. 1999 Nov;
29(11):816-9.
PMID: 10552059
A 6-year-old girl with an inflammatory myofibroblastic tumour of the lung is presented. The radiological features of this lesion are often atypical, as in this case, presenting as progressive atelectasis....
4.
Verberne A
Allergy
. 1999 Jul;
54 Suppl 49:51-4.
PMID: 10422748
Bronchodilators, especially beta2-agonists, are effective in relieving asthma symptoms. Therefore, short-acting beta2-agonists are recommended in all guidelines on a p.r.n. basis, usually in combination with anti-inflammatory treatment, at least in...
5.
Verberne A, Fuller R
Respir Med
. 1998 Aug;
92(5):777-82.
PMID: 9713640
In an attempt to establish the protection afforded by regular salmeterol use against induced bronchoconstriction in asthmatic patients, a meta-analysis was conducted on nine double-blind clinical trials that fulfilled the...
6.
Verberne A, Frost C, Duiverman E, Grol M, Kerrebijn K
Am J Respir Crit Care Med
. 1998 Jul;
158(1):213-9.
PMID: 9655732
Studies in adults revealed that addition of salmeterol to a moderate dose of inhaled corticosteroid resulted in better symptom control and higher PEF compared with doubling the dose of inhaled...
7.
Boot A, de Jongste J, Verberne A, Pols H, de Muinck Keizer-Schrama S
Pediatr Pulmonol
. 1998 Feb;
24(6):379-84.
PMID: 9448228
Little is known about the effect of long-term treatment with inhaled corticosteroids (ICS) on bone mineral density (BMD) in asthmatic children. In the present cross-sectional study BMD, bone metabolism, height,...
8.
Verberne A
Pediatr Pulmonol Suppl
. 1997 Oct;
15:46-50.
PMID: 9316102
International guidelines indicate that the primary goals of asthma treatment are minimizing symptoms and preventing exacerbations. Symptoms last for short periods of time (minutes or hours) and usually disappear either...
9.
Verberne A, Frost C, Roorda R, van der Laag H, Kerrebijn K
Am J Respir Crit Care Med
. 1997 Oct;
156(3 Pt 1):688-95.
PMID: 9309980
The aim of this study was to compare the effects of salmeterol and beclomethasone on lung function and symptoms in children with mild to moderate asthma. Sixty-seven children not treated...
10.
Verberne A, Hop W, Creyghton F, Van Rooij R, van den Berg M, de Jongste J, et al.
J Allergy Clin Immunol
. 1996 Apr;
97(4):938-46.
PMID: 8655889
Background: Inhalation of a single dose of the long-acting beta 2-adrenoceptor agonist salmeterol protects against methacholine-induced airway obstruction and other bronchoconstricting stimuli for at least 12 hours. Hypothetically, twice daily...